With the expansion of risk-based monitoring (RBM) capabilities comes the need to clearly understand the ramifications on patient safety, data quality and clinical trial costs. This webinar will address some of the top mistakes made during the evaluation of risk-based monitoring technologies and provide forward looking insights into key developments affecting the future of RBM including adaptive monitoring, data surveillance and integrated data management.

Learning Objectives:

• Overview of the current state of risk-based monitoring
• Identification of common misconceptions regarding the efficacy and value of RBM
• Targeted recommendations focusing on key business and technology priorities

Who Should Attend:

Pharmaceutical and biotechnology professionals involved with managing clinical trials.

Registration

Registration is complimentary.
A valid business Email address is required to attend.

This webinar is complimentary.